StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)

Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –

Utah Medical Products total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Utah Medical Products's total debt was $195.00K at Jun 30, 2026. For fiscal 2025 it was $225.00K, down 20.2% from the year before. The highest annual figure on record is $16.24M in fiscal 2011.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$225.00K-20.2%
FY2024Dec 31, 2024$282.00K-4.4%
FY2023Dec 31, 2023$295.00K–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$973.00K-80.8%
FY2013Dec 31, 2013$5.07M-43.7%
FY2012Dec 31, 2012$9.00M-44.6%
FY2011Dec 31, 2011$16.24M+1686.8%
FY2010Dec 31, 2010$909.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$195.00K-30.9%
Q1 FY2026Mar 31, 2026$210.00K-28.8%
Q4 FY2025Dec 31, 2025$225.00K–
Q1 FY2025Mar 31, 2025$269.00K–
Q4 FY2024Dec 31, 2024$282.00K–
Q4 FY2023Dec 31, 2023$295.00K–
Q4 FY2015Dec 31, 2015$0–

More Utah Medical Products figures

See a number that looks wrong?